Abstract
To study the effect of bioactive glass bone substitute granules (S53P4) and hypoxic atmospheric conditions on human osteoblastic cell adhesion on different biomaterials. Cellular adhesion and cytoskeletal organization were studied on titanium, polytetrafluoroethylene, polydimethylsiloxane and S53P4 plates in the presence or absence of S53P4 granules. Cells used were human osteoblast-like SaOS-2 cells. The experiments were done either in normal atmospheric conditions or in hypoxia which simulates conditions prevailing in chronically infected bone or bone cavities. Vinculin-containing focal adhesions, organization of actin cytoskeleton and nuclear staining of cells on biomaterial surfaces were studied at 4.5 h, 2 and 4 days. In normoxic conditions S53P4 granules alkalinized the cell culture medium but cellular adhesion and cytoskeletal organization were usually not affected by their presence. Hypoxic conditions associated with lower pH and impaired cellular adhesion, vinculin-containing focal adhesion formation and rearrangement of the actin filaments to actin cytoskeleton. On most materials studied in hypoxic conditions, however, S53P4 granules prevented this impairment of cellular adhesion and cytoskeletal reorganization. The S53P4 granules promote the adhesion of SaOS-2 cells to various biomaterial surfaces especially in hypoxic conditions, in which S53P4 granules increase pH. The presence of S53P4 granules may protect biomaterial surface from bacterial colonization and promote osteointegration of implants used together with S53P4 granules for fixation and weight bearing.
Graphical Abstract
Similar content being viewed by others
References
Stoor P, Pulkkinen J, Grenman R. Bioactive glass S53P4 in the filling of cavities in the mastoid cell area in surgery for chronic otitis media. Ann Otol Rhinol Laryngol. 2010;119(6):377–82.
Yung M, Tassone P, Moumoulidis I, Vivekanandan S. Surgical management of troublesome mastoid cavities. J Laryngol Otol. 2011;125(3):221–6.
Peltola M, Aitasalo K, Suonpaa J, Varpula M, Yli-Urpo A. Bioactive glass S53P4 in frontal sinus obliteration: a long-term clinical experience. Head Neck. 2006;28(9):834–41.
Issing PR, Schonermark M, Kempf HG, Lenarz T. Indications for middle ear obliteration within the scope of cochlear implant management. Laryngorhinootologie. 1996;75(12):727–31.
Leppäranta O, Vaahtio M, Peltola T, Zhang D, Hupa L, Hupa M, et al. Antibacterial effect of bioactive glasses on clinically important anaerobic bacteria in vitro. J Mater Sci Mater Med. 2008;19:547–51.
Munukka E, Leppäranta O, Korkeamäki M, Vaahtio M, Peltola T, Zhang D, et al. Bactericidal effects of bioactive glasses on clinically important aerobic bacteria. J Mater Sci Mater Med. 2008;19:27–32.
Jones JR. Review of bioactive glass: from Hench to hybrids. Acta Biomater. 2013;9(1):4457–86.
Hench LLPH. Direct chemical bond of bioactive glass-ceramic materials to bone and muscle. J Biomed Mater Res. 1973;7(3):25–42.
Passeri G, Cacchioli A, Ravanetti F, Galli C, Elezi E, Macaluso GM. Adhesion pattern and growth of primary human osteoblastic cells on five commercially available titanium surfaces. Clin Oral Implants Res. 2010;21(7):756–65.
Okumura A, Goto M, Goto T, Yoshinari M, Masuko S, Katsuki T, et al. Substrate affects the initial attachment and subsequent behavior of human osteoblastic cells (Saos-2). Biomaterials. 2001;22(16):2263–71.
Baxter LC, Frauchiger V, Textor M, Ap Gwynn I, Richards RG. Fibroblast and osteoblast adhesion and morphology on calcium phosphate surfaces. Eur Cell Mater. 2002;4:1–17.
Suominen E, Kinnunen J. Bioactive glass granules and plates in the reconstruction of defects of the facial bones. Scand J Plast Reconstr Surg Hand Surg. 1996;30(4):281–9.
Wilson J, Clark AE, Hall M, Hench LL. Tissue response to bioglass endosseous ridge maintenance implants. J Oral Implantol. 1993;19(4):295–302.
Stoor P, Soderling E, Grenman R. Interactions between the bioactive glass S53P4 and the atrophic rhinitis-associated microorganism klebsiella ozaenae. J Biomed Mater Res. 1999;48(6):869–74.
Cui X, Zhao C, Gu Y, Li L, Wang H, Huang W, et al. A novel injectable borate bioactive glass cement for local delivery of vancomycin to cure osteomyelitis and regenerate bone. J Mater Sci Mater Med. 2014;25(3):733–45.
Felding Ju, Rasmussen JB, Lildholdt T. Gas composition of the normal and the ventilated middle ear cavity. Scand J Clin Lab Invest Suppl. 1987;186:31–41.
Ostfeld EJ, Silberberg A. Transient pressure changes in the middle ear. Arch Otolaryngol Head Neck Surg. 1991;117(12):1390–4.
Luntz M, Levi D, Sade J, Herman M. Relationship between the gas composition of the middle ear and the venous blood at steady state. Laryngoscope. 1995;105(5 Pt 1):510–2.
Hergils L, Magnuson B. Human middle ear gas composition studied by mass spectrometry. Acta Otolaryngol. 1990;110(1–2):92–9.
Spencer JA, Ferraro F, Roussakis E, Klein A, Wu J, Runnels JM, et al. Direct measurement of local oxygen concentration in the bone marrow of live animals. Nature. 2014;508(7495):269–73.
Gristina AG. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science. 1987;237(4822):1588–95.
Stoor P, Soderling E, Grenman R. Bioactive glass S53P4 in repair of septal perforations and its interactions with the respiratory infection-associated microorganisms Haemophilus influenzae and Streptococcus pneumoniae. J Biomed Mater Res. 2001;58(1):113–20.
Stoor P, Söderling E, Salonen J. Antibacterial effects of a bioactive glass paste on oral microorganisms. Acta Odontol Scand. 1998;56(3):161–5.
Romano CL, Logoluso N, Meani E, Romano D, De Vecchi E, Vassena C, et al. A comparative study of the use of bioactive glass S53P4 and antibiotic-loaded calcium-based bone substitutes in the treatment of chronic osteomyelitis: a retrospective comparative study. Bone Joint J. 2014;96-B(6):845–50.
Lehto VP, Virtanen I. Vinculin in cultured bovine lens-forming cells. Cell Differ. 1985;16(3):153–60.
Soininen A, Kaivosoja E, Sillat T, Virtanen S, Konttinen YT, Tiainen VM. Osteogenic differentiation on DLC-PDMS-h surface. J Biomed Mater Res B Appl Biomater. 2014. doi:10.1002/jbm.b.33125.
Bacakova L, Filova E, Parizek M, Ruml T, Svorcik V. Modulation of cell adhesion, proliferation and differentiation on materials designed for body implants. Biotechnol Adv. 2011;29(6):739–67.
Brunette DM, Chehroudi B. The effects of the surface topography of micromachined titanium substrata on cell behavior in vitro and in vivo. J Biomech Eng. 1999;121(1):49–57.
Zaidel-Bar R, Geiger B. The switchable integrin adhesome. J Cell Sci. 2010;123(Pt 9):1385–8.
Coraca-Huber DC, Fille M, Hausdorfer J, Putzer D, Nogler M. Efficacy of antibacterial bioactive glass S53P4 against S. aureus biofilms grown on titanium discs in vitro. J Orthop Res. 2014;32(1):175–7.
Drago L, Romano D, De Vecchi E, Vassena C, Logoluso N, Mattina R, et al. Bioactive glass BAG-S53P4 for the adjunctive treatment of chronic osteomyelitis of the long bones: an in vitro and prospective clinical study. BMC Infect Dis. 2013;13:584.
DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA. 2007;104(49):19345–50.
Acknowledgments
This project was financially supported by the FinskaLäkaresällskapet, Sigrid Jusélius Foundation, and the special subsidiary funding of the Helsinki University Hospital.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pérez-Tanoira, R., Kinnari, T.J., Hyyrynen, T. et al. Effects of S53P4 bioactive glass on osteoblastic cell and biomaterial surface interaction. J Mater Sci: Mater Med 26, 246 (2015). https://doi.org/10.1007/s10856-015-5568-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10856-015-5568-2